Genetic heterogeneity and transcriptional plasticity drive resistance during immunotherapy and targeted therapy by Reinard Dummer
KEYNOTE SPEAKER PRESENTATION Open Access
Genetic heterogeneity and transcriptional
plasticity drive resistance during immunotherapy
and targeted therapy
Reinard Dummer
From Melanoma Bridge Meeting 2014
Naples, Italy. 03-06 December 2014
Cancer is caused by genetic, epigenetic and microenviron-
mental changes that facilitate the survival and proliferation
of tumor cells and their ability to acquire invasive proper-
ties. The plasticity of human tumor cells generally repli-
cates normal molecular processes occurring during
development and tissue repair. In humans, cancer progres-
sion is also shaped by host immune responses that edit the
final tumor-host interactions. The genetic complexity and
extreme variability of human melanoma means a multidis-
ciplinary integrative approach is needed to understand the
interactions between the genetic background of the host,
the tumor and its microenvironment, and the impact of
these on the immune system. It is becoming evident that
successful anti-tumor strategies need to encompass a mul-
timodal approach to avoid tumor escape or relapse, com-
bining agents able to block essential signal transduction
pathways with immunotherapy.
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